Teladoc (TDOC) Reports Q4 Loss of $0.76, Slight Beat on Revenues; Offers FY18 EPS Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Teladoc (TDOC) Reports Expanded Collaboration with Microsoft (MSFT)
March 1, 2018 4:43 PM ESTTeladoc, Inc. (NYSE: TDOC) announced today its expanded collaboration with Microsoft (NYSE: MSFT). The organizations will be working together to advance the delivery of telehealth, with Teladocs platform running on the Microsoft Azure cloud platform. As a result of the joint go-to-market strategy, hospitals and health systems across the U.S. will have greater access to... More
Teladoc (TDOC) PT Lowered to $47 at Chardan Capital Markets, Keeps 'Buy'
February 28, 2018 7:29 AM ESTChardan Capital Markets lowered its price target on Teladoc (NYSE: TDOC) to $47.00 (from $48.00) while maintaining a Buy rating.
Analyst Steven Wardell commented, "After market close on Tue., TDOC reported earnings in-line with Consensus and maintained its preliminary 2018 revenue and adjusted EBITDA estimate... More
Teladoc (TDOC) PT Raised to $43 at Cowen; Sees Potential Upside to 2018 Guide
February 28, 2018 6:46 AM ESTCowen raised its price target on Teladoc (NYSE: TDOC) to $43.00 (from $39.00) while maintaining an Outperform rating following results.
Analyst Charles Rhyee sees potential upside to 2018 guidance.
... More